Curie Institute, GenoSplice Combine Forces to ID Predictive Cancer Biomarkers | GenomeWeb

Curie-Cancer and GenoSplice Technology this week announced a five-year partnership that will combine their respective expertise in cancer research and bioinformatics services.

Curie-Cancer oversees industry partnerships for the Curie Institute, a cancer research foundation located in Paris. Researchers there work on cancer-centered projects in cell biology, immunology, human genetics and oncogenesis, pharmacochemistry, and more.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.